Ivan Krivega

VP of Gene Therapy @SonoThera

South San Francisco, CA, US
EMAILS
i•••@sonothera.com
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2025 — Present

VP of Gene Therapy @SonoThera

View department →

South San Francisco, CA, US

Leading a cross-functional team of 25+ scientists spanning vector development, research-grade manufacturing, and analytical functions.Providing strategic leadership for drug candidates development across key pipeline programs.Supporting both internal and external communications with key stakeholders and strategic partners.

EDUCATION

1998 — 2002

Lomonosov Moscow State University (MSU)

Bachelor's degree, Genetics

2003 — 2007

Institute of Gene Biology

PhD, Molecular genetics

2002 — 2003

Lomonosov Moscow State University (MSU)

Master's degree, Genetics

SKILLS

PcrProtein PurificationStem CellsMiseqRDrosophila GeneticsMicroscopyIpsImmunofluorescenceAffinity ChromatographyChromatin Capture Assay (3c)DrosophilaFaireIps Derived HepatocytesConfocal MicroscopyAavCrispriCellEmbryonic Stem CellsRnaiGene EditingMolecular GeneticsBiologyMolecular CloningGene TherapyScienceBiochemistryDnaPythonMouse ModelsElectroporationChromatin ImmunoprecipitationQpcrChip-SeqDnase I Sensitivity AssayPurificationProtein ExpressionChipmentationGuide-SeqResearch

ABOUT IVAN KRIVEGA

Energetic leader with over 20 years of experience in advancing genetic medicine from discovery through early clinical development- Proven track record in building organizations, leading cross-functional R&D teams, and developing next-generation viral and non-viral genetic medicine drugs- Founding leader instrumental in scaling a start-up from inception through Series A, inventing the core technology, and driving development of multiple therapeutic programs across rare disease, CNS, kidney, hematologic, cardiovascular, and neuromuscular indications- Subject matter expert across a broad range of genetic medicine technologies, including viral and non-viral gene therapy, gene editing, oligonucleotides, and RNAi therapeutics.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.